GlassScriptPhysician profile
Jennifer Bader
NPI 1407163983
$847.57
in general payments reported to CMS, 2019-2025
13 companies · $657 in 2025
The $657 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $168 · 2024: $22.55 · 2025: $657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $679.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $148.84 | 2021-2025 | Xtandi |
| Bayer Healthcare Pharmaceuticals INC. | $133.89 | 2025 | |
| Ferring Pharmaceuticals INC. | $102.01 | 2025 | Adstiladrin |
| Sumitomo Pharma America, INC. | $98.28 | 2025 | Gemtesa, Orgovyx |
| Teleflex LLC | $71.16 | 2021-2025 | Barrigel |
| Civco Medical Instruments | $55.00 | 2025 | |
| Boston Scientific Corporation | $46.24 | 2024-2025 | Spaceoar System, Ams 700 |
| Astrazeneca Pharmaceuticals LP | $44.35 | 2025 | Lynparza |
| Novartis Pharmaceuticals Corporation | $41.25 | 2025 | |
| Merck Sharp & Dohme LLC | $33.27 | 2025 | Keytruda |
| Blue Earth Diagnostics | $26.50 | 2025 | Posluma |
| Janssen Biotech, INC. | $25.00 | 2025 | Erleada |
| Tolmar, INC. | $21.78 | 2025 | Jatenzo, Eligard |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Bader listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.